A randomised, double-blind, placebo controlled, first-in-human study to investigate the safety, tolerability, and pharmacokinetic and pharmacodynamic response of SLN360 in subjects with elevated lipoprotein(a)

Project: Research

Project Details

StatusActive
Effective start/end date30/09/21 → 29/09/26

Keywords

  • clinical trial
  • treatment safety
  • treatment efficacy
  • Pharmacokinetics
  • pharmacodynamic responses